62 related articles for article (PubMed ID: 21710645)
1. Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations.
Edgerton N; Cohen C; Siddiqui MT
Diagn Cytopathol; 2013 Jan; 41(1):35-40. PubMed ID: 21710645
[TBL] [Abstract][Full Text] [Related]
2. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
Loghavi S; Walts AE; Bose S
Diagn Cytopathol; 2013 Jul; 41(7):582-7. PubMed ID: 22833355
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
Sharma P; Gupta P; Gupta N; Suri V; Rajwanshi A
Turk Patoloji Derg; 2021; 37(1):32-38. PubMed ID: 33372263
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
Singh M; Mockler D; Akalin A; Burke S; Shroyer A; Shroyer KR
Cancer Cytopathol; 2012 Feb; 120(1):26-34. PubMed ID: 22162342
[TBL] [Abstract][Full Text] [Related]
5. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
[TBL] [Abstract][Full Text] [Related]
6. The use of p16/Ki-67 dual staining technology on cervical cytology of patients undergoing a LLETZ procedure.
Packet B; Poppe W; Weynand B; Vanherck M
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():191-196. PubMed ID: 30007246
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
8. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
9. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations.
Nassar A; O'Reilly K; Cohen C; Siddiqui MT
Diagn Cytopathol; 2008 Mar; 36(3):142-8. PubMed ID: 18232003
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review.
Tjalma WAA
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():275-280. PubMed ID: 28086168
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
14. The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
Voidăzan TS; Budianu MA; Cotoi OS; Turdean SG
Rom J Morphol Embryol; 2024; 65(1):99-105. PubMed ID: 38527989
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
16. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
20. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]